HR Execs on the Move

John Staurulakis Inc

www.jsitel.com

 
JSI is a full-service consulting firm and broadband solutions leader, providing a complete range of operational, financial, management, engineering, regulatory, and strategic assistance to independent, community-based communications providers for nearly 60 years. Notably, JSI can assist with designing and operating broadband networks, funding applications, forecasting, competitive pricing, mapping, feasibility studies, intercarrier billing, operational reform, strategic partnerships, company valuations, and more. We also offer a full range of OSP and ISP engineering services, including central office, optical transport, FTTx, IPTV, CATV, and wireless. JSI has more than 460 professionals on staff in its Maryland headquarters and in its regional offices in ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.jsitel.com
  • 7852 Walker Drive Suite 200
    Greenbelt, MD USA 20770
  • Phone: 301.459.7590

Executives

Name Title Contact Details
Patrick Gault
 Chief Revenue Officer Profile

Similar Companies

Septentrio

Septentrio NV is a designer and manufacturer of high-end multi-frequency GNSS receivers.

Cabot Partners

Cabot Partners is a New York, NY-based company in the Business Services sector.

Productive Staffing

Productive Staffing is a Poplar Bluff, MO-based company in the Business Services sector.

Prime Point Media

Prime Point Media is a Norcross, GA-based company in the Business Services sector.

Whitehawk Therapeutics

Whitehawk Therapeutics is an ADC-focused oncology company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Building on the momentum of drug conjugate technologies, Whitehawks three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers, including in significant populations like lung and ovarian. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. As a pragmatic, discerning and agile organization, we are unafraid to make boldly pragmatic choices. Were experts in the business of biotech, from therapeutics R&D through commercialization, applying our collective talents to intentional drug development. More information on the Company is available at www.whitehawktx.com.